ReviewRMD open2016
Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example.
Zhihong Lai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled ittrialcites it